首页> 外文期刊>Current Science: A Fortnightly Journal of Research >The burden of haemoglobinopathies in India and the challenges ahead [Review]
【24h】

The burden of haemoglobinopathies in India and the challenges ahead [Review]

机译:印度的血红蛋白病的负担和未来的挑战[综述]

获取原文
获取原文并翻译 | 示例
       

摘要

Among the inherited disorders of blood, haemoglobinopathy and thalassaemia constitute a major bulk of noncommunicable genetic diseases in India. They cause a high degree of morbidity, moderate to severe haemolytic anaemia among vulnerable segments of the society like infants and children, adolescent girls, pregnant women, etc. and several deaths in India. It has been estimated that with a population of 1000 million at the new millennium (2000) and a birth rate of 25 per thousand, there would be about 45 million carriers and about 15,000 infants born each year with haemoglobinopathies in India. The carrier frequency of haemoglobinopathy varies between 3 and 17% in different populations of India. The cumulative gene frequency of the three most predominant abnormal haemoglobins, i.e. sickle cell, haemoglobin D and haemoglobin E has been found to be 5.35% in India. This article provides glimpses of haemoglobinopathy and thalassaemia with special emphasis on the epidemiology, diagnosis and clinical profile, and hematological characteristics, distribution and prevalent mutations in India. The current status and challenges of haemoglobinopathies have also been highlighted and discussed with special reference to India. [References: 117]
机译:在遗传性血液疾病中,血红蛋白病和地中海贫血是印度非传染性遗传疾病的主要部分。它们在婴儿,儿童,少女,孕妇等社会弱势群体中引起高发病率,中度至重度溶血性贫血,并在印度造成多人死亡。据估计,在新千年(2000年)有10亿人口,每25千人中有一个出生率,印度每年将有约4500万携带者和约15,000婴儿患有血红蛋白病。在印度的不同人群中,血红蛋白病的携带者频率在3%至17%之间变化。在印度,三种最主要的异常血红蛋白,即镰状细胞,血红蛋白D和血红蛋白E的累积基因频率为5.35%。本文简要介绍了血红蛋白病和地中海贫血,并着重介绍了印度的流行病学,诊断和临床概况以及血液学特征,分布和流行突变。血红蛋白病的现状和挑战也得到了强调和讨论,并特别提到了印度。 [参考:117]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号